Reassessing Twenty Years of Vaccine Development Against Tuberculosis
Tuberculosis (TB) remains the prime bacterial infection worldwide with 10.4 million infections and a death toll of 1.7 million people in 2016 according to WHO statistics. Tuberculosis is caused by members of the Mycobacterium tuberculosis complex, facultative intracellular bacteria able to thrive wi...
Saved in:
Main Author: | Stefan H. Kaufmann (auth) |
---|---|
Other Authors: | Ulrich E. Schaible (auth) |
Format: | Book Chapter |
Published: |
Frontiers Media SA
2018
|
Subjects: | |
Online Access: | Get Fullteks DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Host-Directed Therapies for Tuberculosis
Published: (2020) -
Tuberculosis in Adults and Children
by: Caws, Maxine
Published: (2015) -
Advances in DNA Vaccines
Published: (2021) -
Protective Immune Response to Dengue Virus Infection and Vaccines: perspectives from the field to the bench
by: Scott Halstead
Published: (2015) -
Leishmaniasis: From Innate and Adaptive Immunity to Vaccine Development
Published: (2020)